SCHEMBL18601635

SCHEMBL18601635

CC(C)(C)OC(=O)N1CC[C@@H](N)C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.45
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
MAPT P10636 2/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
APEX1 P27695 1/20 0.43
KDM4E B2RXH2 1/20 0.40
THRB P10828 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
HPGD P15428 1/20 0.39
DPP4 P27487 2/20 0.38
GPR119 Q8TDV5 1/20 0.38
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4102268 1.00 KDM1A (0.45) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL29282704 1.00 KDM1A (0.45) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL4705113 0.90 PDE4A (0.42) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL26627498 0.83 KDM1A (0.45) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL14927315 0.81 PDE4A (0.44) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL3747054 0.81 PDE4A (0.44) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL625914 0.81 PDE4A (0.44) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL8276850 0.81 PDE4A (0.44) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL18618732 0.81 PDE4A (0.44) KDM1APDE4APDE4BPDE4CPDE4D
SCHEMBL17977215 0.80 ROCK2 (0.47) KDM1APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118027017-A BRM inhibitor 苏州信诺维医药科技股份有限公司 2024-05-14 CN disclosed
EP-1688418-B1 Chemokine receptor antagonists and methods of use thereof MILLENNIUM PHARM INC (US) 2017-03-15 EP disclosed